Evidence map›Paper›PMID 41569045›Full record

ArticleMicrobiology spectrum2026

Corn silk extract as a prebiotic exerts antihypertensive effects via gut microbiota modulation in hypertensive rats.

Guixiang Yao, Tongxue Zhang, Zihan Qin, Yu Wang, Junfei Gu, Chuan He, Jiajia Jin

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guixiang YaoState Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.ORCID 0009-0006-5843-5762
Tongxue ZhangCheeloo College of Medicine, Shandong University, Jinan, China.
Zihan QinCheeloo College of Medicine, Shandong University, Jinan, China.
Yu WangAffiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Junfei GuDepartment of Endocrinology, the Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Chuan HeDepartment of Endocrinology, the Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Jiajia JinState Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.ORCID 0009-0000-5124-0811

Funding

Anhui Province Health and Wellness Research Project AHWJ2023c049Anhui Province Health and Wellness Research Project AHWJ2024BAc20018Wuhu Science and Technology Bureau Research Project and Wannan Medical College Scientific Research Fund 2023yf126, WK2023ZQNZ61Youth Project of Anhui Provincial Natural Science Foundation 2308085QH260
6 · The paper itself

Abstract

Corn silk extract (CSE), a traditional medicinal food rich in polysaccharides, flavonoids, and saponins, has been used as a natural antihypertensive agent, but its mechanism remains unclear. This study aimed to evaluate whether CSE can lower blood pressure through gut microbiota modulation. Spontaneously hypertensive rats received oral CSE for 4 weeks, followed by a 4-week drug-free observation. The treatment significantly reduced blood pressure, increased microbial diversity, decreased the IMPORTANCE: This study identifies corn silk extract (CSE) as a novel plant-derived prebiotic with antihypertensive effects mediated through gut microbiota modulation. Using a spontaneously hypertensive rat model, we demonstrated that CSE reshapes gut microbial composition, enhances microbial diversity, and promotes beneficial genera while reducing systemic inflammation and restoring nitric oxide (NO)-mediated vascular function. Importantly, fecal microbiota transplantation confirmed the causal role of gut microbiota in mediating these effects. These findings highlight a gut microbiota-inflammation-NO axis as a key pathway through which CSE regulates blood pressure. As a safe, accessible, and food-compatible intervention, CSE represents a promising strategy for non-pharmacological blood pressure management and broadens the application scope of prebiotics in cardiovascular health.

Indexed as

Antihypertensive AgentsGastrointestinal MicrobiomeHypertensionPlant ExtractsPrebioticsZea maysAnimalsBacteriaBlood PressureCytokinesFecal Microbiota TransplantationMaleNitric OxideRatsRats, Inbred SHRAntihypertensive AgentsCytokinesNitric OxidePlant ExtractsPrebioticscorn silk extractgut microbiota remodelinghost healthhypertensionprebioticsystemic inflammation

Identifiers

PMID41569045
PMCPMC12955481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.